Japan Tissue Engineering Co (TSE:7774) Total Liabilities: 円593 Mil (As of Mar. 2026)


TSE:7774 Japan Tissue Engineering Co Ltd TSE:7774
60 GF Score
Price 円646.00
GF Value 円517.24
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Japan Tissue Engineering Co Total Liabilities?

Japan Tissue Engineering Co TSE:7774 +2.54% 60 Total Liabilities is 円593 Mil as of Mar. 2026. GuruFocus rates TSE:7774 with a GF Score™ of 60/100 and a GF Value™ of 円517.24 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Japan Tissue Engineering Co's Total Liabilities for the quarter that ended in Mar. 2026 was 円593 Mil.

Japan Tissue Engineering Co's quarterly Total Liabilities declined from Mar. 2025 (円687.95 Mil) to Sep. 2025 (円648.54 Mil) and declined from Sep. 2025 (円648.54 Mil) to Mar. 2026 (円592.71 Mil).

Japan Tissue Engineering Co's annual Total Liabilities declined from Mar. 2024 (円908.43 Mil) to Mar. 2025 (円687.95 Mil) and declined from Mar. 2025 (円687.95 Mil) to Mar. 2026 (円592.71 Mil).

Japan Tissue Engineering Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Japan Tissue Engineering Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Tissue Engineering Co Total Liabilities Chart

Japan Tissue Engineering Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 931.66 946.15 908.43 687.95 592.71

Japan Tissue Engineering Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 908.43 632.18 687.95 648.54 592.71
TSE:7774
60GF Score
Japan Tissue Engineering Co Ltd TSE:7774
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Tissue Engineering Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Japan Tissue Engineering Co's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=560.509+(0+-7.105427357601E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+32.2+0)
=593

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=5682.993-5090.284
=593

Japan Tissue Engineering Co's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=560.509+(0+-7.105427357601E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+32.2+0)
=593

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=5682.993-5090.284
=593

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of 円593 Mil mean?
Japan Tissue Engineering Co (TSE:7774) has a Total Liabilities of 円593 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Japan Tissue Engineering Co and its competitors.
Is Japan Tissue Engineering Co's Total Liabilities too high?
Japan Tissue Engineering Co's current Total Liabilities is 円593 Mil. Overall, Japan Tissue Engineering Co has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's Total Liabilities compare to VRTX and REGN?
Japan Tissue Engineering Co's Total Liabilities of 円593 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Japan Tissue Engineering Co and its competitors. Japan Tissue Engineering Co's current Total Liabilities is 円593 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Modestly Overvalued. The stock's GF Value™ is 円517.24, compared to a current price of 円646.00 — trading 24.9% above its estimated fair value. The current Total Liabilities is 円593 Mil. Japan Tissue Engineering Co's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current Total Liabilities is 円593 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued. The current stock price of 円646.00 is trading 24.9% above its estimated GF Value™ of 円517.24. GuruFocus considers Japan Tissue Engineering Co to be Modestly Overvalued.

Key valuation signals for TSE:7774:

  • Total Liabilities: 円593 Mil
  • GF Value™: 円517.24 vs. price of 円646.00 (24.9% above fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Japan Tissue Engineering Co Business Description

Address 6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
60GF Score

Get the complete analysis for TSE:7774

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円646.00
Price
円517.24
GF Value